653 related articles for article (PubMed ID: 22301213)
1. Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitors.
Ha YM; Park YJ; Kim JA; Park D; Park JY; Lee HJ; Lee JY; Moon HR; Chung HY
Eur J Med Chem; 2012 Mar; 49():245-52. PubMed ID: 22301213
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of 2-(substituted phenyl)thiazolidine-4-carboxylic acid derivatives as novel tyrosinase inhibitors.
Ha YM; Park YJ; Lee JY; Park D; Choi YJ; Lee EK; Kim JM; Kim JA; Park JY; Lee HJ; Moon HR; Chung HY
Biochimie; 2012 Feb; 94(2):533-40. PubMed ID: 21945595
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of hydroxy substituted phenyl-benzo[d]thiazole analogues for antityrosinase activity in B16 cells.
Ha YM; Park JY; Park YJ; Park D; Choi YJ; Kim JM; Lee EK; Han YK; Kim JA; Lee JY; Moon HR; Chung HY
Bioorg Med Chem Lett; 2011 Apr; 21(8):2445-9. PubMed ID: 21397499
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and preliminary in vitro biological evaluation of 5-chloro-2-(substituted phenyl)benzo[d]thiazole derivatives designed as novel antimelanogenesis agents.
Ha YM; Uehara Y; Park D; Jeong HO; Park JY; Park YJ; Lee JY; Lee HJ; Song YM; Moon HR; Chung HY
Appl Biochem Biotechnol; 2012 Nov; 168(6):1416-33. PubMed ID: 22968587
[TBL] [Abstract][Full Text] [Related]
5. Structural requirement of phenylthiourea analogs for their inhibitory activity of melanogenesis and tyrosinase.
Thanigaimalai P; Lee KC; Sharma VK; Joo C; Cho WJ; Roh E; Kim Y; Jung SH
Bioorg Med Chem Lett; 2011 Nov; 21(22):6824-8. PubMed ID: 21978680
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Novel Synthetic Tyrosinase Inhibitor (
Bang E; Noh SG; Ha S; Jung HJ; Kim DH; Lee AK; Hyun MK; Kang D; Lee S; Park C; Moon HR; Chung HY
Molecules; 2018 Dec; 23(12):. PubMed ID: 30551624
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of dihydropyrimidin-(2H)-one analogues and rhodanine derivatives as tyrosinase inhibitors.
Liu J; Wu F; Chen L; Hu J; Zhao L; Chen C; Peng L
Bioorg Med Chem Lett; 2011 Apr; 21(8):2376-9. PubMed ID: 21411319
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and evaluation of (E)-N-substituted benzylidene-aniline derivatives as tyrosinase inhibitors.
Bae SJ; Ha YM; Park YJ; Park JY; Song YM; Ha TK; Chun P; Moon HR; Chung HY
Eur J Med Chem; 2012 Nov; 57():383-90. PubMed ID: 23149255
[TBL] [Abstract][Full Text] [Related]
9. Anti-melanogenic effect of (Z)-5-(2,4-dihydroxybenzylidene) thiazolidine-2,4-dione, a novel tyrosinase inhibitor.
Kim SH; Ha YM; Moon KM; Choi YJ; Park YJ; Jeong HO; Chung KW; Lee HJ; Chun P; Moon HR; Chung HY
Arch Pharm Res; 2013 Oct; 36(10):1189-97. PubMed ID: 23812774
[TBL] [Abstract][Full Text] [Related]
10. Analogs of 5-(substituted benzylidene)hydantoin as inhibitors of tyrosinase and melanin formation.
Ha YM; Kim JA; Park YJ; Park D; Kim JM; Chung KW; Lee EK; Park JY; Lee JY; Lee HJ; Yoon JH; Moon HR; Chung HY
Biochim Biophys Acta; 2011 Jun; 1810(6):612-9. PubMed ID: 21397665
[TBL] [Abstract][Full Text] [Related]
11. Novel Anti-Melanogenic Compounds, (
Choi H; Ryu IY; Choi I; Ullah S; Jung HJ; Park Y; Jeong Y; Hwang Y; Hong S; Yoon IS; Yun H; Kim MS; Yoo JW; Jung Y; Chun P; Moon HR
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443550
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of polyhydroxy benzophenone as mushroom tyrosinase inhibitors.
Wu J; Hu X; Ma L
J Enzyme Inhib Med Chem; 2011 Jun; 26(3):449-52. PubMed ID: 20939763
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of hydroxy- or methoxy-substituted 5-benzylidene(thio) barbiturates as novel tyrosinase inhibitors.
Chen Z; Cai D; Mou D; Yan Q; Sun Y; Pan W; Wan Y; Song H; Yi W
Bioorg Med Chem; 2014 Jul; 22(13):3279-84. PubMed ID: 24857777
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of in vitro and in vivo anti-melanogenic activity of a newly synthesized strong tyrosinase inhibitor (E)-3-(2,4 dihydroxybenzylidene)pyrrolidine-2,5-dione (3-DBP).
Chung KW; Park YJ; Choi YJ; Park MH; Ha YM; Uehara Y; Yoon JH; Chun P; Moon HR; Chung HY
Biochim Biophys Acta; 2012 Jul; 1820(7):962-9. PubMed ID: 22498140
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the inhibition of mushroom tyrosinase and cellular tyrosinase activities of oxyresveratrol: comparison with mulberroside A.
Kim JK; Park KT; Lee HS; Kim M; Lim YH
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):495-503. PubMed ID: 21827364
[TBL] [Abstract][Full Text] [Related]
16. A newly synthesized, potent tyrosinase inhibitor: 5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol.
Choi J; Bae SJ; Ha YM; No JK; Lee EK; Lee JS; Song S; Lee H; Suh H; Yu BP; Chung HY
Bioorg Med Chem Lett; 2010 Aug; 20(16):4882-4. PubMed ID: 20619644
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory properties of aromatic thiosemicarbazones on mushroom tyrosinase: Synthesis, kinetic studies, molecular docking and effectiveness in melanogenesis inhibition.
Hałdys K; Goldeman W; Jewgiński M; Wolińska E; Anger N; Rossowska J; Latajka R
Bioorg Chem; 2018 Dec; 81():577-586. PubMed ID: 30248509
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol as a kcat type inhibitor for tyrosinase: potentiated melanogenesis inhibitor.
Satooka H; Kubo I
Bioorg Med Chem; 2012 Jan; 20(2):1090-9. PubMed ID: 22189272
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of a novel series of bis-salicylaldehydes as mushroom tyrosinase inhibitors.
Delogu G; Podda G; Corda M; Fadda MB; Fais A; Era B
Bioorg Med Chem Lett; 2010 Oct; 20(20):6138-40. PubMed ID: 20813526
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors.
Jun N; Hong G; Jun K
Bioorg Med Chem; 2007 Mar; 15(6):2396-402. PubMed ID: 17267225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
